BCLI stock

Brainstorm Cell Therapeutics, Inc. [NASDAQ: BCLI] stock went on a downward path that fall over -20.21% on Tuesday, amounting to a one-week price decrease of less than -18.98%. The company report on April 9, 2024 at 6:00 AM that BrainStorm Cell Therapeutics Announces Agreement with

Brainstorm Cell Therapeutics, Inc. [NASDAQ: BCLI] price surged by 42.54 percent to reach at $0.15. The company report on March 6, 2024 at 6:12 AM that BCLI: Unveils Plans for Phase 3b Trial of NurOwn® in ALS…. By David Bautz, PhD. The one-year BCLI stock